| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/24/2010 | US20100160225 Lefty, lefty derivatives and uses thereof |
| 06/24/2010 | US20100159587 Antibodies against human angiopoietin 2 |
| 06/24/2010 | US20100159486 Biomarkers for neurological conditions |
| 06/24/2010 | US20100159477 Reagents for the detection of protein phosphorylation in signaling pathways |
| 06/24/2010 | US20100159453 Genes involved in intestinal inflammatory diseases and use thereof |
| 06/24/2010 | US20100159450 Dpyd gene variants and use thereof |
| 06/24/2010 | US20100159442 Magnetic recognition system |
| 06/24/2010 | US20100159030 Methods for detecting and modulating the sensitivity of tumor cells to anti-mitotic agents and for modulating turmorgenicity |
| 06/24/2010 | US20100158934 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/24/2010 | US20100158932 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof |
| 06/24/2010 | US20100158928 Immune response modifier compositions and methods |
| 06/24/2010 | US20100158927 Antibodies, methods and kits for diagnosing and treating melanoma |
| 06/24/2010 | US20100158926 Antibodies to erbb2 |
| 06/24/2010 | US20100158924 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 06/24/2010 | US20100158922 Anti-Interferon Gamma Antibodies and Methods of Use Thereof |
| 06/24/2010 | US20100158920 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
| 06/24/2010 | US20100158917 Methods for diagnosing cancer and decreasing metastasis by cancer cells |
| 06/24/2010 | US20100158913 Antibody Molecules Having Specificity for Human IL-1B |
| 06/24/2010 | US20100158912 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence |
| 06/24/2010 | US20100158910 Treatment of renal cell carcinoma with anti-cd70 antibody-drug conjugates |
| 06/24/2010 | US20100158909 Variant Target Binding Agents and Uses Thereof |
| 06/24/2010 | US20100158907 Connective tissue growth factor fragments and methods and uses thereof |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158902 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 06/24/2010 | US20100158900 Anti-marinobufagenin antibodies and methods for their use |
| 06/24/2010 | US20100158899 Protein formulation |
| 06/24/2010 | US20100158896 Antibody that specifically binds hyaluronan synthase |
| 06/24/2010 | US20100158893 Systems and methods for obtaining immunoglobulin from blood |
| 06/24/2010 | US20100158892 Pest control |
| 06/24/2010 | US20100158809 Truncated pap2 and methods of making and using same |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/24/2010 | US20100158802 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; colon cancer |
| 06/24/2010 | US20100155590 Labeled transition metal complexes |
| 06/24/2010 | CA2747644A1 Method for generation of immunoglobulin sequences |
| 06/24/2010 | CA2747534A1 Non-human transgenic animals expressing humanised antibodies and use therof |
| 06/24/2010 | CA2747064A1 Monoclonal antibodies directed against lg4/5 domain of alpha3 chain of human laminin-5 |
| 06/24/2010 | CA2747062A1 Myostatin binding proteins |
| 06/24/2010 | CA2746778A1 Human anti-alpha-synuclein autoantibodies |
| 06/24/2010 | CA2744624A1 Antibodies against human angiopoietin 2 |
| 06/24/2010 | CA2743433A1 Anti-cmet antibody |
| 06/24/2010 | CA2706317A1 Doc1 compositions and methods for treating cancer |
| 06/23/2010 | EP2199795A2 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 06/23/2010 | EP2199393A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 06/23/2010 | EP2199391A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 06/23/2010 | EP2199390A1 Anti-epha2 antibody |
| 06/23/2010 | EP2199382A2 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin |
| 06/23/2010 | EP2199307A1 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 06/23/2010 | EP2199306A2 VEGF-specific human antibody |
| 06/23/2010 | EP2198884A1 Monoclonal antibodies directed against LG4-5 domain of alpha3 chain of human laminin-5 |
| 06/23/2010 | EP2198879A1 CD74 modulator agent for regulating dendritic cell migration and device for studying the motility capacity of a cell |
| 06/23/2010 | EP2198870A1 Activator for blood coagulation factor vii promoter and utilization of the same |
| 06/23/2010 | EP2197918A1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 06/23/2010 | EP2197916A1 Fixed single injection dosage for ocrelizumab (2h7) |
| 06/23/2010 | EP2197915A1 Method for the treatment of glomerulonephritis |
| 06/23/2010 | EP2197914A1 HUMANIZED ANTIBODIES AGAINST THE ß-AMYLOYD PEPTIDE |
| 06/23/2010 | EP2197913A2 Anti-ricin antibody |
| 06/23/2010 | EP2197912A2 Anti-chikungunya monoclonal antibodies and uses thereof |
| 06/23/2010 | EP2197911A2 Homogeneous antibody populations |
| 06/23/2010 | EP2197490A2 Compositions that bind multiple epitopes of igf-1r |
| 06/23/2010 | EP1613348B1 Methods for modulating angiogenesis with apelin compositions |
| 06/23/2010 | EP1572748B1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| 06/23/2010 | EP1400550B1 Branched polyalkylene glycols |
| 06/23/2010 | CN1894275B Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 06/23/2010 | CN1820026B Human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors |
| 06/23/2010 | CN1777443B Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 06/23/2010 | CN101754980A Prevention and treatment of complement-associated eye conditions |
| 06/23/2010 | CN101754979A Monoclonal antibodies for treatment of cancer |
| 06/23/2010 | CN101754978A The ED-A antigen of fibrinogen is associated with the neovas culature of tumor metastases |
| 06/23/2010 | CN101754977A Variable tangential flow filtration |
| 06/23/2010 | CN101754976A Complexes of Grp94 with human immunoglobulin G |
| 06/23/2010 | CN101754771A Inhibition of tumor metastasis by anti neuropilin 2 antibodies |
| 06/23/2010 | CN101750486A Method for labeling antibody by fluorophore generated by combination of iridium coordination compound and histidine |
| 06/23/2010 | CN101748145A Recombinant yeast for expressing antibody or antibody analogue as well as construction method and application thereof |
| 06/23/2010 | CN101748140A Schistosoma japonica glyceraldehyde-3-phosphate dehydrogenase gene and encoded protein and application thereof |
| 06/23/2010 | CN101748139A Schistosoma japonica enolase gene and coding protein and application thereof |
| 06/23/2010 | CN101748138A Schistosoma japonica superoxide dismutase gene and a coding protein and application thereof |
| 06/23/2010 | CN101748136A Expression of cymbidium mosaic virus coat protein gene and preparation method for antibody of cymbidium mosaic virus coat protein gene |
| 06/23/2010 | CN101748130A Method for constructing human monoclonal antibody fragment complex |
| 06/23/2010 | CN101748129A Preparation method of anthropogenic hepatitis B virus surface antibody |
| 06/23/2010 | CN101748128A Schistosoma japonica titin gene and coding protein and application thereof |
| 06/23/2010 | CN101748127A Schistosoma japonica actin gene and a coding protein and application thereof |
| 06/23/2010 | CN101747436A Specific antibody against pesticide phosmet |
| 06/23/2010 | CN101747435A Monoclonal antibody (hybrid tumor) for neutralizing CYR61 and applications thereof |
| 06/23/2010 | CN101747434A Chicken pox-herpes zoster human immune globulin and material production method thereof |
| 06/23/2010 | CN101747433A Dracorhodin enzyme linked immunization detection method and application |
| 06/23/2010 | CN101747429A Specific antibody against pesticide meta-tolyl-N-methylcarbamate |
| 06/23/2010 | CN101747428A Specific antibody against pesticide deltamethrin |
| 06/23/2010 | CN101747425A Protein relevant to retina photoreaction as well as coding gene and applications thereof |
| 06/23/2010 | CN101747422A Schistosoma japonica fatty acid-binding protein and coding gene and application thereof |
| 06/23/2010 | CN101747415A Rabbit anti-human MARVELD1 peptide polyclonal antibody and preparation method thereof |
| 06/23/2010 | CN101745112A Treatment of TNFalpha related disorders |
| 06/23/2010 | CN101205253B Immune method for preparing antibody |
| 06/23/2010 | CN101045750B Extraction process of camel colostrum immune globulin IgA, IgG. |
| 06/22/2010 | US7741454 Biological low-molecular-weight derivatives |
| 06/22/2010 | US7741451 Antibodies that specifically bind hedgehog-derived polypeptides |
| 06/22/2010 | US7741450 has neutralizing activity against granulocyte-macrophage colony stimulating factor; cancer, infectious, or autoimmune disease |
| 06/22/2010 | US7741449 inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21, IFN beta or IFN omega; autoimmune diseases, transplant rejection and graft versus host disease; immunoconjugates |
| 06/22/2010 | US7741448 produced by using a liposome containing a GM1 ganglioside at a predetermined ratio as an immunogen; Alzheimer's disease |
| 06/22/2010 | US7741447 Antibody against tumor specific antigen as target |